95 related articles for article (PubMed ID: 9367545)
1. Interleukin-12-mediated killer activity in lung cancer patients.
Haku T; Yanagawa H; Nabioullin R; Takeuchi E; Sone S
Cytokine; 1997 Nov; 9(11):846-52. PubMed ID: 9367545
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of interleukin 10 on interleukin 12- and interleukin 2-mediated killer induction from blood mononuclear cells.
Pai K; Yanagawa H; Takauchi E; Suzuki Y; Hanibuchi M; Parajuli P; Sone S
Oncol Res; 1998; 10(6):295-300. PubMed ID: 9848100
[TBL] [Abstract][Full Text] [Related]
3. Exogenous interleukin 2 regulates interleukin 6 and nitric oxide but not interferon gamma and tumor necrosis factor alpha production in bronchoalveolar leukocytes from patients with small cell lung cancer.
Cembrzyńska-Nowak M; Bieńkowska M; Szklarz E
Arch Immunol Ther Exp (Warsz); 1998; 46(6):367-74. PubMed ID: 9883316
[TBL] [Abstract][Full Text] [Related]
4. Interleukin (IL-)15 has less activity than IL-2 to promote type 2 cytokine predominance in tumour-associated mononuclear cells from lung cancer patients.
Takeuchi E; Yanagawa H; Suzuki Y; Shinkawa K; Bando H; Sone S
Cytokine; 2001 Jan; 13(2):119-23. PubMed ID: 11145853
[TBL] [Abstract][Full Text] [Related]
5. A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.
Motohashi S; Nagato K; Kunii N; Yamamoto H; Yamasaki K; Okita K; Hanaoka H; Shimizu N; Suzuki M; Yoshino I; Taniguchi M; Fujisawa T; Nakayama T
J Immunol; 2009 Feb; 182(4):2492-501. PubMed ID: 19201905
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2-inducible killer activity and its regulation by blood monocytes from autologous lymphocytes of lung cancer patients.
Sone S; Kunishige E; Fawzy F; Yanagawa H; Nii A; Maeda K; Atagi S; Heike Y; Nishioka Y; Mizuno K
Jpn J Cancer Res; 1991 Jun; 82(6):716-23. PubMed ID: 1649813
[TBL] [Abstract][Full Text] [Related]
8. Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation.
Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Yamaguchi K; Fukuhara S
J Cancer Res Clin Oncol; 2002 Jan; 128(1):29-36. PubMed ID: 11862469
[TBL] [Abstract][Full Text] [Related]
9. [Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer].
Sakamoto M; Mikasa K; Hamada K; Konishi M; Maeda K; Yoshimoto E; Ueda K; Majima T; Sawaki M; Kita E; Narita N
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2259-66. PubMed ID: 9881083
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
[TBL] [Abstract][Full Text] [Related]
11. Influence of systemic chemotherapy on anti-P-glycoprotein antibody-dependent cell-mediated cytotoxicity in patients with small cell lung cancer.
Nabioullin R; Yanagawa H; Haku T; Hiramatsu K; Yano S; Hanibuchi M; Pai K; Tsuruo T; Sone S
Jpn J Clin Oncol; 1995 Aug; 25(4):124-30. PubMed ID: 7666588
[TBL] [Abstract][Full Text] [Related]
12. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo.
Redlinger RE; Mailliard RB; Lotze MT; Barksdale EM
J Pediatr Surg; 2003 Mar; 38(3):301-7; discussion 301-7. PubMed ID: 12632339
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction.
Asselin-Paturel C; Megherat S; Vergnon I; Echchakir H; Dorothée G; Blesson S; Gay F; Mami-Chouaib F; Chouaib S
Cancer; 2001 Jan; 91(1):113-22. PubMed ID: 11148567
[TBL] [Abstract][Full Text] [Related]
14. Differential interleukin 12 responsiveness for interferon gamma production in advanced stages of cancer patients correlates with performance status.
Uno K; Setoguchi J; Tanigawa M; Kishi A; Ogawa M; Saotome H; Fujiwara H; Kishida T
Clin Cancer Res; 1998 Oct; 4(10):2425-32. PubMed ID: 9796974
[TBL] [Abstract][Full Text] [Related]
15. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
Hafner M; Falk W; Echtenacher B; Männel DN
Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
[TBL] [Abstract][Full Text] [Related]
17. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
18. IL-12-induced production of IL-10 and interferon-gamma by mononuclear cells in lung cancer-associated malignant pleural effusions.
Takeuchi E; Yanagawa H; Suzuki Y; Shinkawa K; Ohmoto Y; Bando H; Sone S
Lung Cancer; 2002 Feb; 35(2):171-7. PubMed ID: 11804690
[TBL] [Abstract][Full Text] [Related]
19. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.
Krause SW; Gastpar R; Andreesen R; Gross C; Ullrich H; Thonigs G; Pfister K; Multhoff G
Clin Cancer Res; 2004 Jun; 10(11):3699-707. PubMed ID: 15173076
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
